Centessa Pharmaceuticals plc was acquired by Eli Lilly in June 2026. CNTA no longer trades, so its trials are no longer stock catalysts and are left off the trial calendar. The records below are kept for reference; the programs now belong to Eli Lilly, and their dates may not have been updated since.
Clinical trial readout dates for Centessa Pharmaceuticals plc, compiled from
ClinicalTrials.gov, alongside the SEC filings where results are announced.
The next expected readout is December 2026.
Next readoutDecember 2026in ~1 month
Upcoming readouts21 Phase 3
Upcoming readouts
Phase 2ORX750
Narcolepsy Type 1; Narcolepsy Type 2 · NCT06752668
December 2026
Recruiting
Phase 2/3cleminorexton
Narcolepsy Type 1; Narcolepsy Type 2 · NCT07598708